Rich joined HealthQuest as a Consulting Partner in 2014 to leverage his 16+ years of healthcare investing experience in both venture capital and small cap public companies. Having begun his career as a physician, surgeon and scientist, Rich understands first-hand how innovative companies can uniquely impact the practice of medicine. Following his career as a surgeon and scientist, he spent 15+ years at Three Arch Partners, a healthcare focused venture capital firm, where he sourced deals, made investments and added value as a Board member. He serves as a Board member on portfolio company Inmediata.

Past investments that he was involved in include Calistoga (Gilead), Visiogen (Abbot),  Cameron (Boston Scientific), Confluent (Tyco), Novacept (Cytyc), Vivant (Tyco), Calibra (J&J), inGenuity (Qiagen), Spiration (Olympus), Sirtris (GSK), Salveo (Catamaran) and ePocrates, (Athena Health).  In addition to HealthQuest, Rich invests in small cap public companies (also focused in healthcare) as the Founder and General Partner of Acuta Capital, which has over $200M in AUM. His experience in following companies through start-up phase, to IPO and beyond as public companies offers him unique perspective at how young companies can best create lasting value.

Rich holds a BS from Stanford University where he graduated Phi Beta Kappa.  He received an MD from Harvard Medical School where he graduated cum laude and was named a Howard Hughes Scholar for his research efforts with the National Institute of Health.  After medical school, he then went to UCSF School of Medicine for surgical residency and then attended Stanford Graduate School of Business where he received an MBA and graduated as an Arjay Miller Scholar.  Rich and his wife reside in San Juan, PR while maintaining long-time ties to the Silicon Valley area.